Abstract
Purpose
Improvement in survival of pediatric acute lymphoblastic leukemia (ALL) has increased the attention to quality of life (QoL) . QoL is impaired during maintenance treatment, but little is known about QoL during induction therapy. Identification of patients with poor QoL during induction will provide opportunities for early interventions, and may subsequently improve future QoL. This national multi-center study aimed to assess QoL and its determinants during ALL induction treatment.
Methods
Proxy reports of the Child Health Questionnaire (CHQ) and the PedsQL cancer version were collected. Child, treatment, and parental characteristics were analyzed as potential determinants in a multiple regression model.
Results
One hundred thirty parents of children participated (response rate 82 %), median child age was 5.7 years and 48 % were female. QoL, as measured with the CHQ, was significantly lower than the norm, the effect sizes were large, and the differences were clinically relevant. Physical QoL was more often affected than psychosocial QoL. Regression models could be constructed for 4/ 10 CHQ scales and 6/ 8 PedsQL cancer scales, accounting for 7 to 36 % of the variance in scores. Impaired QoL was most often associated with older children, girls, and time since diagnosis. Also, father respondents seem to have a lower QoL perception compared to mother respondents although this needs to be confirmed in future research.
Conclusions
Specific counseling for subsets of patients with a higher risk of low QoL during the early phases of therapy is warranted.
Similar content being viewed by others
References
Barr RD, Petrie C, Furlong W, Rothney M, Feeny D (1997) Health-related quality of life during post-induction chemotherapy in children with acute lymphoblastic leukemia in remission: an influence of corticosteroid therapy. Int J Oncol 11:333–339
Cohen J (1977) Statistical power analysis for behavioral sciences. Academic, New York
de Vries MA, van Litsenburg RR, Huisman J, Grootenhuis MA, Versluys AB, Kaspers GJ, Gemke RJ (2008) Effect of dexamethasone on quality of life in children with acute lymphoblastic leukaemia: a prospective observational study. Health Qual Life Outcomes 6:103
Eiser C, Eiser JR (2007) Mother’s ratings of quality of life in childhood cancer: initial optimism predicts improvement over time. Psychol Health 22:535–543
Eiser C, Vance YH, Horne B, Glaser A, Galvin H (2003) The value of the PedsQL™ in assessing quality of life in survivors of childhood cancer. Child Care Health Dev 29:95–102
Eiser C, Eiser JR, Stride CB (2005) Quality of life in children newly diagnosed with cancer and their mothers. Health QualLife Outcomes 3:29
Eiser C, Davies H, Jenney M, Stride C, Glaser A (2006) HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL) . Pediatr Blood Cancer 46:35–39
Janse AJ, Gemke RJBJ, Uiterwaal CS, Van der Tweel I, Kimpen JLL, Sinnema G (2004) Quality of life; patients and doctors don’t always agree: a meta analysis. J Clin Epidemiol 57:661
Kazis LE, Anderson JJ, Meenan RF (1989) Effect sizes for interpreting changes in health status. Med Care 27:S178–S189
Landgraf JM, Abetz L, Ware JA (2006) The CHQ user’s manual. The H\ealth Institute. New England Medical Center 1996, Boston
Landolt MA, Vollrath M, Niggli FK, Gnehm HE, Sennhauser FH (2006) Health-related quality of life in children with newly diagnosed cancer: a one year follow-up study. Health Qual Life Outcomes 4:63
Langeveld NE, Grootenhuis MA, Voute PA, de Haan RJ, van den Bos C (2004) Quality of life, self-esteem and worries in young adult survivors of childhood cancer. Psychooncology 13:867–881
Meeske K, Katz ER, Palmer SN, Burwinkle T, Varni JW (2004) Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia. Cancer 101:2116–2125
Mulligan K, Etheridge A, Kassoumeri L, Wedderburn LR, Newman S (2009) Do mothers and fathers hold similar views about their child’s arthritis? Arthritis Rheum 61:1712–1718
Peeters J, Meitert J, Paulides M, Wiener A, Beck JD, Calaminus G, Langer T (2009) Health-related quality of life (HRQL) in all-patients treated with chemotherapy only: a report from the late effects surveillance system in Germany. Klin Padiatr 221:156–161
Pui CH, Carroll WL, Meshinchi S, Arceci RJ (2011) Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 29:551–565
Raat H, Bonsel GJ, Essink-Bot ML, Landgraf JM, Gemke RJBJ (2002) Reliability and validity of comprehensive health status measures in children: The Child Health Questionnaire in relation to the Health Utilities Index. J Clin Epidemiol 55:67–76
Sitaresmi MN, Mostert S, Gundy CM, Sutaryo VAJP (2008) Health-related quality of life assessment in Indonesian childhood acute lymphoblastic leukemia. Health Qual Life Outcomes 6:96
Sung L, Klaassen RJ, Dix D, Pritchard S, Yanofsky R, Dzolganovski B, Almeida R, Klassen A (2009) Identification of paediatric cancer patients with poor quality of life. Br J Cancer 100:82–88
Sung L, Yanofsky R, Klaassen RJ, Dix D, Pritchard S, Winick N, Alexander S, Klassen A (2011) Quality of life during active treatment for pediatric acute lymphoblastic leukemia. Int J Cancer 128:1213–1220
Theunissen NC, Vogels TG, Koopman HM, Verrips GH, Zwinderman KA, Verloove-Vanhorick SP, Wit JM (1998) The proxy problem: child report versus parent report in health-related quality of life research. Qual Life Res 7:387–397
Varni JW, Burwinkle TM, Katz ER, Meeske K, Dickinson P (2002) The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales. Multidim Fatigue Scale Cancer Module Cancer 94:2090–2106
Varni JW, Burwinkle TM, Seid M, Skarr D (2003) The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr 3:329–341
Veerman A, Kamps W, van den Berg H, van den Berg E, Bökkerink J, Bruin M, van den Heuvel-Eibrink M, Korbijn C, Korthof E, van der Pal K, Stijnen T, van Weel SM, van Weerden J, van Wering E, van der Does-van den Berg A (2009) Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004). Lancet Oncol 10:957–966
Acknowledgments
We would like to thank the DCOG data managers, local physicians, and study managers in all participating centers for including participants and keeping us updated on their clinical condition. Also, we thank Esther Meijer-van den Bergh for helping with the initial design and continuation of this project.
Conflicts of interest
The authors declare that there is no conflict of interest. No financial support was received. The authors are in full control of all primary data and agree to allow Supportive Care in Cancer to review the data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van Litsenburg, R.R.L., Huisman, J., Pieters, R. et al. Determinants of quality of life during induction therapy in pediatric acute lymphoblastic leukemia. Support Care Cancer 22, 3235–3242 (2014). https://doi.org/10.1007/s00520-014-2349-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-014-2349-2